Ningbo Yaoming Medical Technology Co., Ltd.
Ningbo Yaoming Medical Technology Co., Ltd. is located in Ningbo City, Zhejiang Province, on the coast of the East China Sea.Yaoming Medical Technology Company has always prioritized research and innovation as its foundation, sales channels as its basis, digital solutions as its guide, and clinic terminal demands as its orientation. The company adheres to the principles of scientific development and people-oriented approach, boasting a comprehensive management team, robust technical team, stable sales team, and distribution channels.lt has established deep collaborations with relevant hospitals, frontline doctorsand universities, among others, to enhance the "industry-university-research-application" independent innovation model and foster synergistic innovation to empower industry development.Yaoming Medical has always been at the forefront of exploration in the field of minimally invasive surgical instruments and accessories(MISIA),particularly in the MISIA market.With a focus on products such as carbon dioxide insufflators and disposable sterile trocar systems for laparoscopic insufflation,we has achieved significant breakthroughs in technology after long-term research and development efforts.It has successfully overcome technological barriers from foreign sources and pioneered the development of a brand-new laparoscopic insufflation system. After multiple rounds of testing, the performance of the system is on par with high-end foreign products.We has always been dedicated to technological innovation, aiming to provide excellent and comprehensive solutions in the field of minimally invasive surgical instruments for doctors and patients alike.lts commitment extends to expanding the path of the global minimally invasive surgical medical deviceindustry in China.
Ningbo Yaoming Medical Technology Co., Ltd.
Ningbo Yaoming Medical Technology Co., Ltd. is located in Ningbo City, Zhejiang Province, on the coast of the East China Sea.Yaoming Medical Technology Company has always prioritized research and innovation as its foundation, sales channels as its basis, digital solutions as its guide, and clinic terminal demands as its orientation. The company adheres to the principles of scientific development and people-oriented approach, boasting a comprehensive management team, robust technical team, stable sales team, and distribution channels.lt has established deep collaborations with relevant hospitals, frontline doctorsand universities, among others, to enhance the "industry-university-research-application" independent innovation model and foster synergistic innovation to empower industry development.Yaoming Medical has always been at the forefront of exploration in the field of minimally invasive surgical instruments and accessories(MISIA),particularly in the MISIA market.With a focus on products such as carbon dioxide insufflators and disposable sterile trocar systems for laparoscopic insufflation,we has achieved significant breakthroughs in technology after long-term research and development efforts.It has successfully overcome technological barriers from foreign sources and pioneered the development of a brand-new laparoscopic insufflation system. After multiple rounds of testing, the performance of the system is on par with high-end foreign products.We has always been dedicated to technological innovation, aiming to provide excellent and comprehensive solutions in the field of minimally invasive surgical instruments for doctors and patients alike.lts commitment extends to expanding the path of the global minimally invasive surgical medical deviceindustry in China.
Jiangsu Changmei Medtech Co., Ltd.
Jiangsu Changmei Medtech Co., Ltd. was founded in 2013 and specializes in the design, research, and production of all kinds of minimally invasive medical devices, with a particular focus on the kyphoplasty system products, dilation balloon catheter products, and endoscopic products, which are all CE certificated, we have a comprehensive strength from the original design, development to batch production.
Our team members have experience and background in different industries in enterprise processes and applications. We cultivate our team with professionalism and pursuit of perfection. Through nearly 10 years of effort, the kyphoplasty balloon catheter already accounts for 80% of the Chinese market, and we also have good cooperation relationships with customers all over the world, including the member companies of Stryker and Medtronic.
We are committed to the development of state-of-the-art and challengeable endoscope products, our 1.0mm mini biopsy forceps, the novel definition of "MADE IN CHINA", the first in China, are compatible with a 1.20mm instrument channel to allow successful sampling. The four-bar linkage structure and alligator tooth cup, which are with stronger push ability and enable a reliable biopsy even in the small bronchi.
The great feedback from the market earns more confidence and determination for the following new product research and development. We will continue to be committed to innovative minimally invasive medical solutions, providing better medical balloon catheters and endoscopy products for patients around the world, improving people's lives, and improving the health quality of patients around the world.
Jiangsu Changmei Medtech Co., Ltd.
Jiangsu Changmei Medtech Co., Ltd. was founded in 2013 and specializes in the design, research, and production of all kinds of minimally invasive medical devices, with a particular focus on the kyphoplasty system products, dilation balloon catheter products, and endoscopic products, which are all CE certificated, we have a comprehensive strength from the original design, development to batch production.
Our team members have experience and background in different industries in enterprise processes and applications. We cultivate our team with professionalism and pursuit of perfection. Through nearly 10 years of effort, the kyphoplasty balloon catheter already accounts for 80% of the Chinese market, and we also have good cooperation relationships with customers all over the world, including the member companies of Stryker and Medtronic.
We are committed to the development of state-of-the-art and challengeable endoscope products, our 1.0mm mini biopsy forceps, the novel definition of "MADE IN CHINA", the first in China, are compatible with a 1.20mm instrument channel to allow successful sampling. The four-bar linkage structure and alligator tooth cup, which are with stronger push ability and enable a reliable biopsy even in the small bronchi.
The great feedback from the market earns more confidence and determination for the following new product research and development. We will continue to be committed to innovative minimally invasive medical solutions, providing better medical balloon catheters and endoscopy products for patients around the world, improving people's lives, and improving the health quality of patients around the world.
Bozhou Leanqe Medical Technology Co., Ltd.
Bozhou Leanqe Medical Technology Co., Ltd. is located in the High-tech Zone of Bozhou city. It is a high-tech enterprise integrating R&D, production and sales of medical devices, covering an area of 50 acres. We have established R&D center and operation center in Shenzhen city and Hefei city, and have R&D offices in the United States. We`re committed to the R&D, innovation and industrialization of medical products, and have a number of independent intellectual property rights. Our products cover three major fields: minimally invasive medical, life monitoring and rehabilitation medical, and provide overall solutions.
Bozhou Leanqe Medical Technology Co., Ltd.
Bozhou Leanqe Medical Technology Co., Ltd. is located in the High-tech Zone of Bozhou city. It is a high-tech enterprise integrating R&D, production and sales of medical devices, covering an area of 50 acres. We have established R&D center and operation center in Shenzhen city and Hefei city, and have R&D offices in the United States. We`re committed to the R&D, innovation and industrialization of medical products, and have a number of independent intellectual property rights. Our products cover three major fields: minimally invasive medical, life monitoring and rehabilitation medical, and provide overall solutions.
Mitutoyo Optical Technology (Shanghai) Co., Ltd.
The Olympus brand was founded in 1919, and in 1921, it independently developed the optical microscope "Xu". For ninety years, Olympus has always been at the forefront of this industry with its core competitiveness of "optical-digital technology", providing precision and professional microscope products to the field of life sciences. With the rapid development of technology, today's microscopes have long bid farewell to the simple optical structure of lenses. The application of microscopes is not limited to observing ordinary chromosomal specimens. With the breakthrough and innovation of Olympus optical technology, various things are more intelligent and more Advanced microscopes have been developed and used to provide reliable support for further exploring the mysteries of life: Olympus FSX100 takes "excellent image", "super simple operation" and "good ergonomic engineering" as its core concepts, and transforms the complexity. In order to simplify, everyone can easily obtain stable and accurate microscope images; the fully built-in laser scanning confocal microscope FV10i obtains a compact structure and a highly stable system through a fully built-in integrated design, making it even more powerful. The complex operation and maintenance of laser confocal microscopes have become history, reflecting the humanized design concept; FV1000-MPE, which has multi-photon laser scanning technology, can deeply observe thick specimens or internal cores of body specimens, and for neuroscience and The research on tissue engineering of artificial organs has had an extremely profound impact, opening a new era of in-depth observation of microscopes. Olympus microscope products have always represented the advanced level of the industry, and are widely used in life sciences and industrial research, and have been well received by users and scientific research institutions. In April 2023, Bain Capital announced that the private equity firm has acquired Evident, former scientific solutions division of Olympus, after obtaining regulatory approval in Japan and other jurisdictions. The Science Division of the Olympus Industrial and Life Sciences business is responsible for Olympus.
Mitutoyo Optical Technology (Shanghai) Co., Ltd.
The Olympus brand was founded in 1919, and in 1921, it independently developed the optical microscope "Xu". For ninety years, Olympus has always been at the forefront of this industry with its core competitiveness of "optical-digital technology", providing precision and professional microscope products to the field of life sciences. With the rapid development of technology, today's microscopes have long bid farewell to the simple optical structure of lenses. The application of microscopes is not limited to observing ordinary chromosomal specimens. With the breakthrough and innovation of Olympus optical technology, various things are more intelligent and more Advanced microscopes have been developed and used to provide reliable support for further exploring the mysteries of life: Olympus FSX100 takes "excellent image", "super simple operation" and "good ergonomic engineering" as its core concepts, and transforms the complexity. In order to simplify, everyone can easily obtain stable and accurate microscope images; the fully built-in laser scanning confocal microscope FV10i obtains a compact structure and a highly stable system through a fully built-in integrated design, making it even more powerful. The complex operation and maintenance of laser confocal microscopes have become history, reflecting the humanized design concept; FV1000-MPE, which has multi-photon laser scanning technology, can deeply observe thick specimens or internal cores of body specimens, and for neuroscience and The research on tissue engineering of artificial organs has had an extremely profound impact, opening a new era of in-depth observation of microscopes. Olympus microscope products have always represented the advanced level of the industry, and are widely used in life sciences and industrial research, and have been well received by users and scientific research institutions. In April 2023, Bain Capital announced that the private equity firm has acquired Evident, former scientific solutions division of Olympus, after obtaining regulatory approval in Japan and other jurisdictions. The Science Division of the Olympus Industrial and Life Sciences business is responsible for Olympus.
B. Braun offers a comprehensive range of surgical instruments, including bone-cutting tools, known for their precision and durability.
B. Braun Melsungen AG
B. Braun offers a comprehensive range of surgical instruments, including bone-cutting tools, known for their precision and durability.
A multinational corporation that develops medical devices, pharmaceuticals, and consumer packaged goods.
Johnson & Johnson
A multinational corporation that develops medical devices, pharmaceuticals, and consumer packaged goods.
Biotronik is a German company specializing in cardiovascular and endovascular devices, including innovative drug-eluting stents.
Biotronik SE & Co. KG
Biotronik is a German company specializing in cardiovascular and endovascular devices, including innovative drug-eluting stents.
Edwards Lifesciences Corporation
Edwards Lifesciences is a global leader in patient-focused medical innovations for structural heart disease and critical care monitoring. They also offer vascular access devices including catheters.
Edwards Lifesciences Corporation
Edwards Lifesciences is a global leader in patient-focused medical innovations for structural heart disease and critical care monitoring. They also offer vascular access devices including catheters.
Meril Life Sciences Pvt. Ltd.
Meril is an Indian company specializing in producing advanced cardiovascular and endovascular devices with a focus on affordability and accessibility.
Meril Life Sciences Pvt. Ltd.
Meril is an Indian company specializing in producing advanced cardiovascular and endovascular devices with a focus on affordability and accessibility.
MicroAire Surgical Instruments, LLC
MicroAire specializes in orthopedic surgical instruments, particularly for joint replacement and reconstructive surgeries.
MicroAire Surgical Instruments, LLC
MicroAire specializes in orthopedic surgical instruments, particularly for joint replacement and reconstructive surgeries.
Boston Scientific Corporation (now part of Boston Scientific)
Conceptus was acquired by Boston Scientific and is known for its gynecological interventional devices, now integrated into Boston Scientific’s offerings.
Boston Scientific Corporation (now part of Boston Scientific)
Conceptus was acquired by Boston Scientific and is known for its gynecological interventional devices, now integrated into Boston Scientific’s offerings.
Arthrex specializes in minimally invasive surgical instruments, including bone-cutting tools, for orthopedic and sports medicine procedures.
Arthrex, Inc.
Arthrex specializes in minimally invasive surgical instruments, including bone-cutting tools, for orthopedic and sports medicine procedures.
Smith & Nephew is a global medical technology company providing innovative bone-cutting tools for orthopedic and trauma surgeries.
Smith & Nephew plc
Smith & Nephew is a global medical technology company providing innovative bone-cutting tools for orthopedic and trauma surgeries.
Integra LifeSciences Corporation
Integra LifeSciences specializes in collagen-based medical products, including wound care and regenerative medicine solutions.
Integra LifeSciences Corporation
Integra LifeSciences specializes in collagen-based medical products, including wound care and regenerative medicine solutions.
Cook Medical Trading (China) Co., Ltd.
Cook Medical is a medical device company from Indiana, USA. It was founded in 1963 by Mr. Bill Cook and his wife. Currently, Cook Medical's business covers 135 countries and regions around the world, with products covering more than 60 professional disciplines, and its production bases are mainly located in the United States, Europe and Australia. It has 6 major logistics distribution centers, multiple local warehousing and distribution centers, as well as more than 10,000 employees worldwide. Since its establishment, Cook Medical has adhered to the operating model of a family business. Unlike listed companies, unique individuality gives full space to consider issues from a long-term perspective, and there is no need to compromise on short-term business interests, truly adhering to the concept, original intention, and realizing the commitment to patients. The company's products have been in the Chinese market for more than 30 years. In 2008, Cook (China) Medical Trading Co., Ltd. was established in Shanghai. Currently, Cook China has two offices in Shanghai and Beijing, of which the Shanghai office is the operation headquarters of Cook China. In the future, Cook Medical will move forward steadily with full enthusiasm and confidence, professional knowledge and rich experience, and provide better products to serve patients and physicians.
Cook Medical Trading (China) Co., Ltd.
Cook Medical is a medical device company from Indiana, USA. It was founded in 1963 by Mr. Bill Cook and his wife. Currently, Cook Medical's business covers 135 countries and regions around the world, with products covering more than 60 professional disciplines, and its production bases are mainly located in the United States, Europe and Australia. It has 6 major logistics distribution centers, multiple local warehousing and distribution centers, as well as more than 10,000 employees worldwide. Since its establishment, Cook Medical has adhered to the operating model of a family business. Unlike listed companies, unique individuality gives full space to consider issues from a long-term perspective, and there is no need to compromise on short-term business interests, truly adhering to the concept, original intention, and realizing the commitment to patients. The company's products have been in the Chinese market for more than 30 years. In 2008, Cook (China) Medical Trading Co., Ltd. was established in Shanghai. Currently, Cook China has two offices in Shanghai and Beijing, of which the Shanghai office is the operation headquarters of Cook China. In the future, Cook Medical will move forward steadily with full enthusiasm and confidence, professional knowledge and rich experience, and provide better products to serve patients and physicians.
Teleflex Medical Device Trading (Shanghai) Co., Ltd.
Teleflex is a global provider of medical technology dedicated to improving people's health and quality of life. Using a goal-driven innovation approach, Teleflex continues to explore unmet clinical needs, providing support to healthcare professionals who are constantly working to create a healthy future. Teleflex’s portfolio offers solutions in vascular access and interventional therapy, surgery, anesthesia, cardiac care, urinary, acute medicine and respiratory care. More than 14,000 Teleflex employees around the world are united and united, believing that what they do every day is of great significance. Teleflex’s brands include Arrow®, Deknatel®, LMA®, Pilling®, QuikClot®, Rüsch®, UroLift® and Weck®.
Teleflex Medical Device Trading (Shanghai) Co., Ltd.
Teleflex is a global provider of medical technology dedicated to improving people's health and quality of life. Using a goal-driven innovation approach, Teleflex continues to explore unmet clinical needs, providing support to healthcare professionals who are constantly working to create a healthy future. Teleflex’s portfolio offers solutions in vascular access and interventional therapy, surgery, anesthesia, cardiac care, urinary, acute medicine and respiratory care. More than 14,000 Teleflex employees around the world are united and united, believing that what they do every day is of great significance. Teleflex’s brands include Arrow®, Deknatel®, LMA®, Pilling®, QuikClot®, Rüsch®, UroLift® and Weck®.
MicroPort Scientific Corporation
Micro-Invasive was founded in Zhangjiang Science City, Shanghai, China in 1998. It is an innovative medical device group, in Shanghai, Suzhou, Jiaxing, Shenzhen, China; Irvine, Memphis, Boston, USA ; Paris, France ; Milan, Italy ; Aachen, Germany ; Oxford, UK; Santo Domingo, Dominican ; Mumbai, India and San Jose, Costa Rica and other places have built major production (R&D) bases, forming a global R&D, production, marketing and service network. In the minimally invasive family, more than 12,000 employees from more than 30 countries are committed to providing patients around the world with universal truth, goodness and beauty solutions that can extend and reshape lives, thereby helping hundreds of millions of earthlings to cross the 115-year-old lifeline. More than 400 products have been launched in minimally invasive products, covering cardiovascular and structural heart disease, electrophysiological and cardiac rhythm management systems, bone and soft tissue repair technology, major arterial and peripheral vascular diseases, cerebrovascular and neuroregulatory science, surgical critical illness and robotics , endocrine management and assisted reproduction, urology and gynecological digestive and respiratory diseases, otolar and nose, mouth and eyes, etc., in vitro diagnosis and internal and external imaging, in vivo solid tumor treatment technology, insomnia and depression and rehabilitation medical twelve major business clusters. Minimally invasive products have entered more than 20,000 hospitals in more than 100 countries around the world. On average, one minimally invasive product is used every 6 seconds to treat patients' lives or improve their quality of life or to help them. Give new life.
MicroPort Scientific Corporation
Micro-Invasive was founded in Zhangjiang Science City, Shanghai, China in 1998. It is an innovative medical device group, in Shanghai, Suzhou, Jiaxing, Shenzhen, China; Irvine, Memphis, Boston, USA ; Paris, France ; Milan, Italy ; Aachen, Germany ; Oxford, UK; Santo Domingo, Dominican ; Mumbai, India and San Jose, Costa Rica and other places have built major production (R&D) bases, forming a global R&D, production, marketing and service network. In the minimally invasive family, more than 12,000 employees from more than 30 countries are committed to providing patients around the world with universal truth, goodness and beauty solutions that can extend and reshape lives, thereby helping hundreds of millions of earthlings to cross the 115-year-old lifeline. More than 400 products have been launched in minimally invasive products, covering cardiovascular and structural heart disease, electrophysiological and cardiac rhythm management systems, bone and soft tissue repair technology, major arterial and peripheral vascular diseases, cerebrovascular and neuroregulatory science, surgical critical illness and robotics , endocrine management and assisted reproduction, urology and gynecological digestive and respiratory diseases, otolar and nose, mouth and eyes, etc., in vitro diagnosis and internal and external imaging, in vivo solid tumor treatment technology, insomnia and depression and rehabilitation medical twelve major business clusters. Minimally invasive products have entered more than 20,000 hospitals in more than 100 countries around the world. On average, one minimally invasive product is used every 6 seconds to treat patients' lives or improve their quality of life or to help them. Give new life.
Straumann (China) Investment Co., Ltd.
Straumann® is a leading brand dedicated to giving people confidence in implantology and related fields. Straumann® represents high-end Swiss quality, accuracy and innovation, backed by a strong global scientific network and is a guarantee of confidence in the dentistry field. As a global leader in oral transplantation, Straumann® continues to make epoch-making innovations. These innovations are supported by scientific evidence and are regarded as industry benchmarks and disruptive technological breakthroughs. Straumann® breaks through limitations and keeps the dental care industry moving forward. Stroman has never been content with traditional solutions, and Stroman's technological advancements are revolutionizing the dental industry. Stroman has launched a breakthrough integrated new transplant system that combines Stroman DNA and innovation. This makes Stroman a truly multi-faceted solution provider in the field of dental aesthetics. Stroman offers a wide range of preventive, conventional and surgical treatment products and solutions, as well as repair and regeneration solutions, and also offers integrated digital workflows, orthodontic treatments and CADCAM restorations for natural aesthetics and greater patient comfort. Schoman cooperates with many medical institutions, research institutions and medical universities around the world to develop and produce dental implants, surgical instruments, CAD/CAM repair, digital product services and tissue regeneration products for oral aesthetic restoration solutions for dental replacement and repair or prevent tooth loss. Today, in the dentistry field, it is a global, flexible, entrepreneurial enterprise. Stroman Group's business in China includes: Planting and repair products: Straumann, Anthogyr, T-plus, Warantec Digital Solutions Business: Straumann CARES Orthodontic business: Clear correct, Smyletec Biomaterials Business: Straumann XenoGraft Bone Meal Multi-platform planting and repair system: Medentika
Straumann (China) Investment Co., Ltd.
Straumann® is a leading brand dedicated to giving people confidence in implantology and related fields. Straumann® represents high-end Swiss quality, accuracy and innovation, backed by a strong global scientific network and is a guarantee of confidence in the dentistry field. As a global leader in oral transplantation, Straumann® continues to make epoch-making innovations. These innovations are supported by scientific evidence and are regarded as industry benchmarks and disruptive technological breakthroughs. Straumann® breaks through limitations and keeps the dental care industry moving forward. Stroman has never been content with traditional solutions, and Stroman's technological advancements are revolutionizing the dental industry. Stroman has launched a breakthrough integrated new transplant system that combines Stroman DNA and innovation. This makes Stroman a truly multi-faceted solution provider in the field of dental aesthetics. Stroman offers a wide range of preventive, conventional and surgical treatment products and solutions, as well as repair and regeneration solutions, and also offers integrated digital workflows, orthodontic treatments and CADCAM restorations for natural aesthetics and greater patient comfort. Schoman cooperates with many medical institutions, research institutions and medical universities around the world to develop and produce dental implants, surgical instruments, CAD/CAM repair, digital product services and tissue regeneration products for oral aesthetic restoration solutions for dental replacement and repair or prevent tooth loss. Today, in the dentistry field, it is a global, flexible, entrepreneurial enterprise. Stroman Group's business in China includes: Planting and repair products: Straumann, Anthogyr, T-plus, Warantec Digital Solutions Business: Straumann CARES Orthodontic business: Clear correct, Smyletec Biomaterials Business: Straumann XenoGraft Bone Meal Multi-platform planting and repair system: Medentika
Terumo (China) Investment Co., Ltd.
Import channels were interrupted during World War I, and Japanese medical scientists made efforts to localize the thermometers as their goal. In 1921, medical scientists led by Dr. Shibasaburo Kitari founded the Telmao Company. Since its establishment, Termau has inherited the innovative challenge spirit of Dr. Beili, implemented the company philosophy of "contributing to society through medical care", and is committed to delivering excellent innovative technologies to the medical site. Telmao Co., Ltd. was founded in 1921. Its products include disposable medical devices, blood transfusion tools series, pharmaceutical and nutritional medicine series, angiography and therapeutic catheter, medical electronic products series, artificial heart and lung product series, etc. Termau's products have been widely used in many countries and regions around the world. Termau's unique technology will make the medical process humanized and gentle. The application of Telmao's new technology can relieve pain and discomfort during medical treatment as much as possible. Telmau has always been committed to developing medical products that meet high standards, not only meeting high standards in terms of safety and precision, but also in maintaining patients' good recovery and quality of life. At present, Telmao has established two factories in Hangzhou and Changchun, China respectively. Termau will dedicate mild, easy-to-use healthcare products and technologies to the world in the 21st century. In order to strengthen the integrated management of R&D, production and sales in China, Telmao applied for the establishment of Telmao (China) Investment Co., Ltd. in August 2012, with a registered capital of US$30 million. According to the early business strategy, the sales ratio of domestic products will be gradually increased in the future. The establishment of Telmao (China) Investment Co., Ltd. has also taken a big step to integrating the Greater China Circle Management Model in the Mainland, Hong Kong, Macau and Taiwan markets.
Terumo (China) Investment Co., Ltd.
Import channels were interrupted during World War I, and Japanese medical scientists made efforts to localize the thermometers as their goal. In 1921, medical scientists led by Dr. Shibasaburo Kitari founded the Telmao Company. Since its establishment, Termau has inherited the innovative challenge spirit of Dr. Beili, implemented the company philosophy of "contributing to society through medical care", and is committed to delivering excellent innovative technologies to the medical site. Telmao Co., Ltd. was founded in 1921. Its products include disposable medical devices, blood transfusion tools series, pharmaceutical and nutritional medicine series, angiography and therapeutic catheter, medical electronic products series, artificial heart and lung product series, etc. Termau's products have been widely used in many countries and regions around the world. Termau's unique technology will make the medical process humanized and gentle. The application of Telmao's new technology can relieve pain and discomfort during medical treatment as much as possible. Telmau has always been committed to developing medical products that meet high standards, not only meeting high standards in terms of safety and precision, but also in maintaining patients' good recovery and quality of life. At present, Telmao has established two factories in Hangzhou and Changchun, China respectively. Termau will dedicate mild, easy-to-use healthcare products and technologies to the world in the 21st century. In order to strengthen the integrated management of R&D, production and sales in China, Telmao applied for the establishment of Telmao (China) Investment Co., Ltd. in August 2012, with a registered capital of US$30 million. According to the early business strategy, the sales ratio of domestic products will be gradually increased in the future. The establishment of Telmao (China) Investment Co., Ltd. has also taken a big step to integrating the Greater China Circle Management Model in the Mainland, Hong Kong, Macau and Taiwan markets.
Pocos International Medical Trading (Shanghai) Co., Ltd.
Boston Science continues to develop breakthrough medical technologies and products, contributing to the progress of multiple medical fields. Committed to reducing patient trauma, reducing medical costs, and effectively improving the quality of life. Boston Science currently owns more than 13,000 life-improving products, and the company invests more than $1 billion in research and development every year. Boston Science is committed to improving people's lives and improving the health quality of patients around the world through innovative medical solutions. Innovating for life is the mission of Boston Science and a commitment to patients, physicians and medical systems around the world. About 30 million patients benefit from Boston’s scientific innovative medical solutions each year.
Pocos International Medical Trading (Shanghai) Co., Ltd.
Boston Science continues to develop breakthrough medical technologies and products, contributing to the progress of multiple medical fields. Committed to reducing patient trauma, reducing medical costs, and effectively improving the quality of life. Boston Science currently owns more than 13,000 life-improving products, and the company invests more than $1 billion in research and development every year. Boston Science is committed to improving people's lives and improving the health quality of patients around the world through innovative medical solutions. Innovating for life is the mission of Boston Science and a commitment to patients, physicians and medical systems around the world. About 30 million patients benefit from Boston’s scientific innovative medical solutions each year.
